1.Exacerbation of Disseminated Superficial Actinic Porokeratosis in a Patient with Colon Cancer.
Kyung Min KIM ; Ji Hyun LEE ; Tae Yoon KIM
Korean Journal of Dermatology 2015;53(6):462-465
Disseminated superficial actinic porokeratosis, a variant of porokeratosis, is an uncommon, hereditary or acquired keratinization disorder. It is characterized histologically by cornoid lamella and clinically by central atrophy with elevated borders. Porokeratosis lesions may be triggered by UV light exposure, infection, hematopoietic malignancies, or immunosuppression, but are rarely reported associated with malignancies of visceral organs. We herein report an unusual case of a patient with colon cancer who noted sudden exacerbation of a previously unrecognized disseminated superficial actinic porokeratosis lesion after being treated with chemotherapy.
Atrophy
;
Colon*
;
Colonic Neoplasms*
;
Drug Therapy
;
Hematologic Neoplasms
;
Humans
;
Immunosuppression
;
Porokeratosis*
;
Ultraviolet Rays
2.Disseminated superficial actinic porokeratosis like drug eruption: a case report.
Sang Min HWANG ; Eung Ho CHOI ; Sung Ku AHN
Journal of Korean Medical Science 1999;14(2):227-229
We report a 54-year-old male patient who developed an unusual form of generalized drug eruption. He had pain and breathlessness on the left chest wall. He had history of taking several drugs at private clinics under a diagnosis of herpes zoster. Two weeks later he had a generalized skin eruption. Examination showed multiple variable sized, mild pruritic, erythematous macules and papules on the face and upper extremities. Skin lesions take the form of a clinically consistent with disseminated superficial actinic porokeratosis (DSAP). Methylprednisolone 16 mg, astemisole 10 mg, oxatomide 60 mg was prescribed. Topical corticosteroid cream was applied. Within two months, his eruption had cleared almost completely. The pathogenetic mechanisms of this case are unclear, but drug and UV light have been considered.
Case Report
;
Drug Eruptions/physiopathology
;
Drug Eruptions/etiology*
;
Drug Eruptions/drug therapy
;
Facial Dermatoses/pathology
;
Facial Dermatoses/drug therapy
;
Facial Dermatoses/chemically induced*
;
Hand Dermatoses/pathology
;
Hand Dermatoses/drug therapy
;
Hand Dermatoses/chemically induced*
;
Herpes Zoster/complications*
;
Human
;
Male
;
Middle Age
;
Porokeratosis/pathology
;
Porokeratosis/drug therapy
;
Porokeratosis/chemically induced*